2Fisher B, Bryant J, Wolmark N, et al. Effect of pre-operative chemotherapy on the outcome of women with operable breast cancer[J]. J Clin Oncol, 1998, 16: 2672.
3Mauriac L, Mac Grogan G, Avail A, et al. Neoadjuvant chemotherapy For operable breast carcinoma larger than 3 cm:A unicentre randomized trial with 124-month median follow-up[J]. Ann Oncol, 1999, 10: 47.
4Broet P, Shcoll S M, De la Rochefordiere A, et al. Short and long term effects on survival in breast cancer patients treated by primary chemotherapy: An updated analysis of a randomized trial[J]. Breast Cancer Res Treat, 1999, 58: 151.
5Bonadonna G, Valagussa P, Brambilla C, et al. Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute [ J ]. J Clin Oncol, 1998, 16 :93.
6Jos A. van der Hage, Cornelis J H, van de Velde, et al. Preoperative chemotherapy in primary operable breast cancer: Results from the European organization for research and treatmentof cancer trial 10902 [J]. J Clin Oneol, 2001, 19:4224.
7Cance W G, Carey L A, Calvo B F, et al. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma:effective clinical downstaging allows breast preservation and predicts outstanding local control and survival[J]. Ann Surg,2002, 236(3): 295.
8Bonadonna G, Valagussa P, Brambilla C, et al. Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy[J]. Semin Oncol, 1991, 18(6):515.
9Bhalla K, and Harris W B. Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer[J]. Semin Oneol, 1998, 25 suppl(3): 19.
10Hutcheon A W, Heys S D, Miller I D, et al. Improvement in survival in patients receiving primary chemotherapy with docetaxel for breast cancer: a randomized controlled trial[J].Breast Cancer Res Treat, 2001, 69(3): 298.
